4//SEC Filing
Higgons John Duncan 4
Accession 0001640455-20-000002
CIK 0001640455other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:56 PM ET
Size
4.9 KB
Accession
0001640455-20-000002
Insider Transaction Report
Form 4
Higgons John Duncan
Director
Transactions
- Sale
Common Stock
2020-01-06$8.11/sh−1,500$12,165→ 12,013 total
Footnotes (2)
- [F1]The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 6, 2019. The Reporting Person exercised no discretion with respect to this transaction.
- [F2]Total adjusted by the transfer of 13,512 shares in a transaction exempt under Rule 16a-12.
Documents
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeother
Related Parties
1- filerCIK 0001581954
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 4:56 PM ET
- Size
- 4.9 KB